VitaSpring Biomedical Co. Ltd. (VSBC)
OTCMKTS · Delayed Price · Currency is USD
0.0111
0.00 (0.00%)
At close: Feb 12, 2026
VitaSpring Biomedical Market Cap
VitaSpring Biomedical has a market cap or net worth of $2.3 million as of February 26, 2026.
Market Cap
2.30M
Enterprise Value
2.40M
Revenue
-1.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since November 13, 2019, VitaSpring Biomedical's market cap has decreased from 22.89M to 2.30M, a decrease of -89.96%. That is a compound annual growth rate of -30.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 2.30M | -99.92% |
| Dec 29, 2022 | 2.97B | -26.15% |
| Dec 27, 2021 | 4.03B | 17,490.12% |
| Nov 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ProtoKinetix | 3.19M |
| Mosaic ImmunoEngineering | 2.90M |
| Enzolytics | 2.90M |
| Vaccinex | 2.76M |
| Sorrento Therapeutics | 2.61M |
| Galera Therapeutics | 2.49M |
| Agentix | 1.95M |
| ZyVersa Therapeutics | 1.94M |